Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dihuang Yizhi Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Longhua Hospital, Shanghai University of Traditional Chinese Medicine, for the treatment of cognitive impairment. The formula typically includes *Rehmannia glutinosa*, *Cornus officinalis*, *Panax ginseng*, *Acorus tatarinowii*, *Polygala tenuifolia*, and *Poria cocos*. It is investigated for its potential to treat subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease. Mechanistically, it is thought to provide neuroprotection by modulating the cholinergic system, reducing neuroinflammation, and inhibiting the accumulation of amyloid-beta plaques.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dihuang Yizhi Formula.